CARRIERE STEPHEN J 4
4 · Evelo Biosciences, Inc. · Filed Jan 21, 2022
Insider Transaction Report
Form 4
CARRIERE STEPHEN J
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-19+6,250→ 6,250 totalExercise: $5.05Exp: 2032-01-19→ Common Stock (6,250 underlying) - Award
Restricted Stock Units
2022-01-19+1,417→ 1,417 totalExercise: $0.00Exp: 2032-01-19→ Common Stock (1,417 underlying)
Footnotes (2)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates.
- [F2]These RSUs will vest in four substantially equal annual installments at the end of each annual anniversary of the date of grant, subject to continued employment on such dates.